Evaxion A/S - Sponsored ADR (EVAX) vs TransCode Therapeutics Inc. (RNAZ)

Evaxion A/S - Sponsored ADR and TransCode Therapeutics Inc. are both Biotechnology companies. Evaxion A/S - Sponsored ADR and TransCode Therapeutics Inc. are of similar size ($27.9M and $27.2M). Across the 10 metrics below, Evaxion A/S - Sponsored ADR leads on 5 and TransCode Therapeutics Inc. on 5.

Valuation

Metric EVAX RNAZ Biotechnology median
P/E n/m n/m 7.88
P/S 2.31 n/m 11.47
P/B 2.59 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.15 0.74
EV/Sales 1.63 n/m 10.73
Earnings yield (29.31%) (3,098.82%) (28.84%)
Free cash flow yield (149.03%) (1,398.93%) (23.03%)

Profitability

Metric EVAX RNAZ Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (96.10%) 429.61% (57.72%)
Return on assets (36.20%) (58.12%) (49.22%)
Return on invested capital (245.79%) 0.00% 0.00%

Growth

Metric EVAX RNAZ Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 89.85% 96.02% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EVAX RNAZ Biotechnology median
Debt to equity 0.71 0.00 0.00
Current ratio 5.06 1.97 4.73
Net debt to EBITDA 1.87 0.64 0.96

Dividend

Metric EVAX RNAZ Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric EVAX RNAZ Biotechnology median
Market cap 27.19m 27.94m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack